- AdventHealth Research Institute
For decades, Type 1 diabetes (T1D) was perceived as a condition that appeared suddenly, transforming a person's life overnight. However, recent research is uncovering a different reality. Scientists have found that T1D develops gradually, often over several years, as the body's immune system begins to attack the insulin-producing cells in the pancreas. This important discovery has paved the way for an extraordinary possibility: the potential for prevention.
At AdventHealth’s Translational Research Institute (TRI) and centers across the country, researchers, scientists, and clinicians are studying ways to identify T1D before symptoms even appear. Through simple blood tests that look for autoantibodies, markers that show the immune system is active against insulin-producing cells, researchers can now detect the earliest signs of the disease, sometimes years before diagnosis.
This early detection means intervention is finally possible. Ongoing studies are exploring new treatments that could protect the pancreas, slow the immune attack, or even stop it entirely. It’s a radical shift moving from waiting to treat diabetes after it develops to finding ways to keep it from starting at all.
For families, that message brings hope. For those who already live with T1D, it means a future where children and grandchildren might never have to face it. For those at risk, it means having time to prepare, monitor, and participate in prevention studies that could make a lasting difference.
What You Can Do This Diabetes Awareness Month
1. Learn your risk.
If someone in your family has T1D, you can get screened for diabetes-related autoantibodies. These tests can reveal your risk level long before symptoms begin.
2. Pay attention to symptoms.
Excessive thirst, frequent urination, fatigue, or unexpected weight loss can all be early signs of diabetes. If you or your child experiences these, see a healthcare provider right away.
3. Support research.
Clinical studies rely on volunteers, both those with and without diabetes, to advance prevention and treatment. Participating or donating helps fuel discoveries that bring us closer to a world without T1D.
4. Share what you learn.
Awareness starts with conversation. Sharing accurate information about prevention and early testing could help someone you know detect diabetes before it becomes dangerous.
Prevention is no longer a far-off dream. Scientists are learning how to recognize T1D before it takes hold, and families are stepping up to be part of that change. Every test, every trial, every conversation brings us closer to a future where T1D may never have a chance to begin.
Recent News
Alcohol, Marijuana and Type 1 Diabetes:
Whether it's a backyard barbecue, a football game or dinner with friends, alcohol and marijuana are common parts of social life. For people with Type 1 diabetes (T1D), understanding how they affect...
GLP-1 Medications: The Next Chapter in Diabetes Care
Ozempic®. Wegovy®. Zepbound®. Just a few years ago, most people had never heard these names. Today, they're among the most talked-about medications in the world. While much of the public conversation...
Q&A: Alcohol, Marijuana and Type 1 Diabetes
A Conversation with Daria Igudesman, PhD, RD, Postdoctoral Research Fellow, AdventHealth Translational Research Institute.
The Science That Moves Medicine Forward:
Have you ever wondered how breakthrough medicines are developed, how doctors determine the most effective treatments, or how healthcare continues to advance? The answer lies in clinical research—the...
Meet Jawanda Thacker: Helping Connect Today's Volunteers to Tomorrow's Medical Breakthroughs
Meet Jawanda Thacker: Helping Connect Today's Volunteers to Tomorrow's Medical Breakthroughs
Six Breakthroughs Shaping the Future of Diabetes Care
Several members of the AdventHealth Translational Research Institute (TRI) team traveled to New Orleans in June to attend the American Diabetes Association's (ADA) 2026 Scientific Sessions, where more...
AHRI Investigator Receives Prestigious American Diabetes Association Junior Faculty Development Award
The AdventHealth Translational Research Institute (TRI) is proud to announce that Dr. Justine Mucinski has received an American Diabetes Association (ADA) Junior Faculty Development Award.
Dr. Richard Pratley Featured in Nature Medicine for Breakthrough Obesity Research
Dr. Richard E. Pratley, senior investigator at the AdventHealth Translational Research Institute, has been featured as the corresponding author of a newly published study in Nature Medicine, one of...
Dr. Sparks Participates in LIMNA’s 17th Annual Metabolism and Aging Symposium
AdventHealth researcher Dr. Lauren Sparks recently had the honor of participating in LIMNA’s 17th Annual Symposium on “Metabolism and Aging” at the Olympic Museum in Lausanne
Advancing Cancer Research Closer to Home
At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...
AdventHealth Research Institute Researchers to Present at American Diabetes Association Scientific Sessions
AdventHealth Research Institute (AHRI) is proud to have a strong presence at the American Diabetes Association (ADA) 2026 Scientific Sessions, with multiple investigators and research team members...
Moving More, Managing Better
For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.